HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma.

ABSTRACT:

SUBMITTER: Stevens WBC 

PROVIDER: S-EPMC7000479 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature